The Health Resources and Services Administration (HRSA) released its Final Rule regarding the calculation of the 340B ceiling price and the imposition of civil monetary penalties (CMPs) on manufacturers that knowingly and...more
1/9/2017
/ Affordable Care Act ,
Civil Monetary Penalty ,
Covered Entities ,
Drug Pricing ,
Final Rules ,
Healthcare ,
HRSA ,
Pharmaceutical Industry ,
Prescription Drugs ,
Section 340B ,
Trump Administration